SEC Form 4 · accession 0000899243-18-029744
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon Snodgres
Officer — CFO
Period of report
Nov 26, 2018
Accepted (ET)
Nov 28, 2018 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 26, 2018 | M | 11,445 | $26.20 | A | 32,344 | D | |
| Common Stock | Nov 26, 2018 | M | 4,000 | $24.50 | A | 36,344 | D | |
| Common Stock | Nov 26, 2018 | M | 6,055 | $32.40 | A | 42,399 | D | |
| Common Stock | Nov 26, 2018 | M | 10,253 | $26.05 | A | 52,652 | D | |
| Common StockF1,F2 | Nov 26, 2018 | S | 31,753 | $63.4874 | D | 20,899 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $26.20 | Nov 26, 2018 | M | 11,445 | D | — | Feb 26, 2025 | Common Stock | 11,445 | 0 | D |
| Stock Option (Right to Buy)F4 | $24.50 | Nov 26, 2018 | M | 4,000 | D | — | Jul 14, 2024 | Common Stock | 4,000 | 2,000 | D |
| Stock Option (Right to Buy)F5 | $32.40 | Nov 26, 2018 | M | 6,055 | D | — | Feb 23, 2027 | Common Stock | 6,055 | 12,110 | D |
| Stock Option (Right to Buy)F6 | $26.05 | Nov 26, 2018 | M | 10,253 | D | — | Feb 26, 2026 | Common Stock | 10,253 | 5,127 | D |
Explanation of responses
- F1Sale of common stock was effective pursuant to a 10(b)5-1 trading plan adopted on September 19, 2018.
- F2$63.4874 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.18 to $64.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3This option is currently exercisable.
- F42,000 shares vest and become exercisable on each of the following dates: 7/14/2015, 7/14/2016, 7/14/2017, 7/14/2018 and 7/14/2019.
- F56,055 shares vest and become exercisable on each of the following dates: 2/23/2018, 2/23/2019 and 2/23/2020.
- F6Shares vest and become exercisable as follows: 5,126 shares on 2/26/2017, 5,127 shares on 2/26/2018 and 5,127 shares on 2/26/2019.